other_material
confidence high
sentiment neutral
materiality 0.40
Alzamend Neuro issues 300,000 shares on conversion of Series B Preferred Stock
Alzamend Neuro, Inc.
- Issued 300,000 common shares upon conversion of 696 Series B Preferred shares between Sep 17-25, 2025.
- Common shares outstanding as of Sep 25, 2025: 3,439,861.
- Shares issued in reliance on Section 4(a)(2) exemption; no registration.
item 3.02item 9.01